• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎生物标志物的研究进展。

Insights of rheumatoid arthritis biomarkers.

机构信息

Department of Internal Medicine, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Department of Biochemistry, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

出版信息

Biomarkers. 2021 May;26(3):185-195. doi: 10.1080/1354750X.2020.1794043. Epub 2021 Feb 10.

DOI:10.1080/1354750X.2020.1794043
PMID:32662676
Abstract

Rheumatoid arthritis is a chronic, autoimmune connective tissue disease. In addition to joint involvement, extra-articular changes and organ complications also occur in the course of the disease. Untreated disease leads to disability and premature death. Therefore, it is important to recognise and begin treatment early. Based on the presence of rheumatoid factor and antibodies against citrullinated peptides, we can distinguish two forms of the disease: seropositive and seronegative. Research continues to elucidate the mechanisms of the onset of the disease, as well as to uncover factors that induce and influence the activity of the disease. The presence of markers that initially appear and affect the course of the disease can potentially aid in patient treatment. In this article, we have collected biomarkers of rheumatoid arthritis that are well understood as well as those that have been recently described.

摘要

类风湿关节炎是一种慢性、自身免疫性结缔组织疾病。除关节受累外,疾病过程中还会发生关节外改变和器官并发症。未经治疗的疾病会导致残疾和过早死亡。因此,早期识别和开始治疗非常重要。根据类风湿因子和抗瓜氨酸肽抗体的存在,我们可以将疾病分为两种形式:血清阳性和血清阴性。研究不断阐明疾病发作的机制,并揭示诱导和影响疾病活动的因素。最初出现并影响疾病进程的标志物的存在可能有助于患者的治疗。本文收集了已充分了解的类风湿关节炎生物标志物以及最近描述的生物标志物。

相似文献

1
Insights of rheumatoid arthritis biomarkers.类风湿关节炎生物标志物的研究进展。
Biomarkers. 2021 May;26(3):185-195. doi: 10.1080/1354750X.2020.1794043. Epub 2021 Feb 10.
2
Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach.采用肽文库方法鉴定血清阴性类风湿关节炎的新型血清学标志物。
Front Immunol. 2021 Oct 5;12:753400. doi: 10.3389/fimmu.2021.753400. eCollection 2021.
3
Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.自身抗体亚型的测定提高了类风湿关节炎血清学诊断的敏感性。
Front Immunol. 2018 Apr 24;9:876. doi: 10.3389/fimmu.2018.00876. eCollection 2018.
4
Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.仅抗瓜氨酸化肽/蛋白抗体阴性的类风湿关节炎的类风湿因子阳性亚组可能血清转化为抗瓜氨酸化肽/蛋白抗体阳性。
Int J Rheum Dis. 2017 Jun;20(6):731-736. doi: 10.1111/1756-185X.13000. Epub 2017 Feb 15.
5
Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.类风湿关节炎自身抗体的临床和病理生理学意义。
Adv Rheumatol. 2019 Jan 17;59(1):2. doi: 10.1186/s42358-018-0042-8.
6
Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.氨甲酰化波形蛋白是拉丁美洲(古巴)类风湿性关节炎患者的一种相关自身抗原。
Rheumatol Int. 2016 Jun;36(6):781-91. doi: 10.1007/s00296-016-3472-9. Epub 2016 Apr 2.
7
From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.从类风湿因子到抗瓜氨酸化蛋白抗体和抗氨甲酰化蛋白抗体:类风湿关节炎患者的诊断和预后预测。
Int J Mol Sci. 2021 Jan 12;22(2):686. doi: 10.3390/ijms22020686.
8
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.同型半胱氨酸化的α1 抗胰蛋白酶作为血清阴性类风湿关节炎患者自身抗体的抗原靶标。
J Autoimmun. 2020 Sep;113:102470. doi: 10.1016/j.jaut.2020.102470. Epub 2020 May 28.
9
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.早期关节炎患者(无类风湿因子和 ACPA)的转归及 ESPOIR 队列中类风湿关节炎的预测因子。
Arthritis Res Ther. 2019 Jun 6;21(1):140. doi: 10.1186/s13075-019-1909-8.
10
Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool.抗瓜氨酸化蛋白抗体:在类风湿关节炎发病机制中的作用及其作为诊断工具的潜力。
Rheumatol Int. 2013 Jul;33(7):1669-73. doi: 10.1007/s00296-012-2635-6. Epub 2013 Feb 1.

引用本文的文献

1
Protease activated receptor inhibitors in rheumatoid arthritis: a new frontier in treatment.类风湿关节炎中的蛋白酶激活受体抑制剂:治疗新前沿
Inflammopharmacology. 2025 Jun 28. doi: 10.1007/s10787-025-01822-x.
2
Quantum Health Accelerator Ameliorates CFA-Induced Animal Model of Rheumatoid Arthritis: Investigating the Role of Immunomodulatory and Anti-Oxidative Effects.量子健康加速器改善胶原诱导的类风湿性关节炎动物模型:探究免疫调节和抗氧化作用的角色。
Brain Sci. 2025 Feb 23;15(3):232. doi: 10.3390/brainsci15030232.
3
Elevated Serum Levels of YKL-40, YKL-39, and SI-CLP in Patients with Treatment Failure to DMARDs in Patients with Rheumatoid Arthritis.
类风湿关节炎患者使用改善病情抗风湿药治疗失败时血清YKL-40、YKL-39和SI-CLP水平升高。
Biomedicines. 2024 Jun 25;12(7):1406. doi: 10.3390/biomedicines12071406.
4
Transformed Salmonella typhimurium SL7207/pcDNA-CCOL2A1 as an orally administered DNA vaccine.经改造的鼠伤寒沙门氏菌SL7207/pcDNA-CCOL2A1作为口服DNA疫苗。
AMB Express. 2024 Jan 9;14(1):6. doi: 10.1186/s13568-023-01650-8.
5
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis.当自身抗体缺失时:血清阴性类风湿关节炎的挑战
Antibodies (Basel). 2023 Oct 31;12(4):69. doi: 10.3390/antib12040069.
6
Platelet and Red Blood Cell Volume Indices in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.类风湿关节炎患者的血小板和红细胞体积指标:一项系统评价与荟萃分析
Diagnostics (Basel). 2022 Oct 30;12(11):2633. doi: 10.3390/diagnostics12112633.
7
FCER1G Gene Hypomethylation in Patients with Rheumatoid Arthritis.类风湿关节炎患者中FCER1G基因低甲基化
J Clin Med. 2022 Aug 9;11(16):4664. doi: 10.3390/jcm11164664.
8
Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis.对新诊断的、未使用过药物的系统性自身免疫性疾病患者的研究表明,裂解肽酪氨酸酪氨酸(PYY 3-36)是类风湿关节炎的特异性血浆生物标志物。
Mediators Inflamm. 2021 Jun 17;2021:5523582. doi: 10.1155/2021/5523582. eCollection 2021.